Bitopertin: The good news and bad news

JAMA Psychiatry

Volumn 71, Issue 6, 2014, Pages 621-622

  Goff, Donald C ^a  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; BITOPERTIN; CLOZAPINE; GLYCINE; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHENCYCLIDINE; PLACEBO; POMAGLUMETAD METHIONIL; RISPERIDONE;

CEREBROSPINAL FLUID ANALYSIS; CLINICAL RESEARCH; DOSE RESPONSE; EDITORIAL; EMISSION TOMOGRAPHY; HUMAN; NEGATIVE SYNDROME; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); PLACEBO EFFECT; RECEPTOR OCCUPANCY; SCHIZOPHRENIA; THERAPY EFFECT;

ANTIPSYCHOTIC AGENTS; FEMALE; GLYCINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; MALE; PIPERAZINES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SULFONES;

EID: 84902180976     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2014.257     Document Type: Editorial

References (8)

1. Umbricht D, Alberati D, Martin-Facklam M, et al. Effect of bitopertin, a glycine reuptake inhibitor, on negative symptoms of schizophrenia: a randomized, double-blind, proof-of-concept study [published online April 2, 2014]. JAMA Psychiatry. doi:10.1001/jamapsychiatry.2014.163.
2. Coyle JT. NMDA receptor and schizophrenia: a brief history. Schizophr Bull. 2012;38(5):920-926.
3. Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry. 1991;148(10):1301-1308.
4. Singh SP, Singh V. Meta-analysis of the efficacy of adjunctive NMDA receptor modulators in chronic schizophrenia. CNS Drugs. 2011;25(10):859-885.
5. Buchanan RW, Javitt DC, Marder SR, et al. The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments. Am J Psychiatry. 2007;164(10):1593-1602. (Pubitemid 350069740)
6. WeiserM, Heresco-Levy U, Davidson M, et al. A multicenter, add-on randomized controlled trial of low-dose d-serine for negative and cognitive symptoms of schizophrenia. J Clin Psychiatry. 2012; 73(6):e728-e734.
7. Nong Y, Huang YQ, JuW, et al. Glycine binding primes NMDA receptor internalization. Nature. 2003;422(6929):302-307. (Pubitemid 36378356)
8. Martin-Facklam M, Pizzagalli F, Zhou Y, et al. Glycine transporter type 1 occupancy by bitopertin: a positron emission tomography study in healthy volunteers. Neuropsychopharmacology. 2013;38 (3):504-512.